Early Fetal Echocardiography: Ready for Prime Time?

Abstract

The objective of this study was to examine the performance of early fetal echocardiography as a screening tool for major cardiac defects in a high-risk population. Fetal echocardiograms performed at 12 to 16 weeks were reviewed. Cases that did not undergo a follow-up echocardiogram at 18 to 22 weeks were excluded. Results of the early and follow-up echocardiograms were compared. Over a 4-year period, 119 early fetal echocardiograms were recorded. Of those, 81 (68%) had follow-up fetal echocardiograms. Results of the early echocardiogram were normal in 77 of 81 (95.1%) cases. Of these, the follow-up was normal in 75 of these 77 cases; in the remaining 2, the follow-up raised suspicion for a ventricular septal defect (VSD) in one and persistent left superior vena cava in the other. On the other hand, the early echocardiogram was abnormal in 4 (4.9%) cases: (1) atrioventricular canal defect, with the follow-up demonstrating a VSD; (2) hypoplastic right ventricle and transposition of the great arteries, confirmed on follow-up; (3) VSD and coarctation of the aorta, confirmed on follow-up. In the fourth case, the early echocardiogram suspected a VSD and right-left disproportion, yet the follow-up was normal. In conclusion, early fetal echocardiography appears to be a reasonable screening tool for major cardiac defects.

Keywords

fetal echocardiography - fetal heart - congenital heart disease - prenatal diagnosis

• References

• 1 Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39 (12) 1890-1900
• 2 Montaña E, Khoury MJ, Cragan JD, Sharma S, Dhar P, Fyfe D. Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well defined birth population, Atlanta, Georgia, 1990–1994. J Am Coll Cardiol 1996; 28 (7) 1805-1809
• 3 Buskens E, Steyerberg EW, Hess J, Wladimiroff JW, Grobbee DE. Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health 1997; 87 (6) 962-967
• 4 Crawford DC, Chita SK, Allan LD. Prenatal detection of congenital heart disease: factors affecting obstetric management and survival. Am J Obstet Gynecol 1988; 159 (2) 352-356
• 5 Sharland GK, Lockhart SM, Chita SK, Allan LD. Factors influencing the outcome of congenital heart disease detected prenatally. Arch Dis Child 1991; 66 (3) 284-287
• 6 Vergani P, Mariani S, Ghidini A , et al. Screening for congenital heart disease with the four-chamber view of the fetal heart. Am J Obstet Gynecol 1992; 167 (4 Pt 1) 1000-1003
• 7 Davis GK, Farquhar CM, Allan LD, Crawford DC, Chapman MG. Structural cardiac abnormalities in the fetus: reliability of prenatal diagnosis and outcome. Br J Obstet Gynaecol 1990; 97 (1) 27-31
• 8 Smythe JF, Copel JA, Kleinman CS. Outcome of prenatally detected cardiac malformations. Am J Cardiol 1992; 69 (17) 1471-1474
• 9 Bonnet D, Coltri A, Butera G , et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99 (7) 916-918
• 10 Chang AC, Huhta JC, Yoon GY , et al. Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg 1991; 102 (6) 841-848
• 11 Sharland G. Routine fetal cardiac screening: what are we doing and what should we do?. Prenat Diagn 2004; 24 (13) 1123-1129
• 12 Johnson B, Simpson LL. Screening for congenital heart disease: a move toward earlier echocardiography. Am J Perinatol 2007; 24 (8) 449-456
• 13 Cheitlin MD, Alpert JS, Armstrong WF , et al. ACC/AHA Guidelines for the clinical application of echocardiography. Circulation 1997; 95 (6) 1686-1744
• 14 Allan LD. Fetal echocardiography. Clin Obstet Gynecol 1988; 31 (1) 61-79
• 15 Small M, Copel JA. Indications for fetal echocardiography. Pediatr Cardiol 2004; 25 (3) 210-222
• 16 Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7 (4) 245-250
• 17 Hyett JA, Perdu M, Sharland GK, Snijders RS, Nicolaides KH. Increased nuchal translucency at 10–14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997; 10 (4) 242-246
• 18 Mavrides E, Cobian-Sanchez F, Tekay A , et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001; 17 (2) 106-110
• 19 Zosmer N, Souter VL, Chan CSY, Huggon IC, Nicolaides KH. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 1999; 106 (8) 829-833
• 20 Schwärzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10–14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999; 106 (10) 1029-1034
• 21 Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17 (2) 102-105
• 22 Simpson LL, Malone FD, Bianchi DW , et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007; 109 (2 Pt 1) 376-383
• 23 Bahado-Singh RO, Wapner R, Thom E , et al; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening Study Group. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005; 192 (5) 1357-1361
• 24 Vogel M, Sharland GK, McElhinney DB , et al. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype. Cardiol Young 2009; 19 (5) 441-445
• 25 Malone FD, Ball RH, Nyberg DA , et al; FASTER Trial Research Consortium. First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol 2005; 106 (2) 288-294
• 26 Haak MC, Twisk JWR, Van Vugt JMG. How successful is fetal echocardiographic examination in the first trimester of pregnancy?. Ultrasound Obstet Gynecol 2002; 20 (1) 9-13
• 27 Souka AP, Pilalis A, Kavalakis Y, Kosmas Y, Antsaklis P, Antsaklis A. Assessment of fetal anatomy at the 11-14-week ultrasound examination. Ultrasound Obstet Gynecol 2004; 24 (7) 730-734
• 28 Vimpelli T, Huhtala H, Acharya G. Fetal echocardiography during routine first-trimester screening: a feasibility study in an unselected population. Prenat Diagn 2006; 26 (5) 475-482
• 29 Smrcek JM, Berg C, Geipel A, Fimmers R, Diedrich K, Gembruch U. Early fetal echocardiography: heart biometry and visualization of cardiac structures between 10 and 15 weeks’ gestation. J Ultrasound Med 2006; 25 (2) 173-182, quiz 183–185
• 30 Becker R, Wegner RD. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol 2006; 27 (6) 613-618
• 31 Smrcek JM, Berg C, Geipel A , et al. Detection rate of early fetal echocardiography and in utero development of congenital heart defects. J Ultrasound Med 2006; 25 (2) 187-196
• 32 Carvalho JS, Moscoso G, Tekay A, Campbell S, Thilaganathan B, Shinebourne EA. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart 2004; 90 (8) 921-926
• 33 Comas Gabriel C, Galindo A, Martínez JM , et al. Early prenatal diagnosis of major cardiac anomalies in a high-risk population. Prenat Diagn 2002; 22 (7) 586-593
• 34 Gembruch U, Knöpfle G, Bald R, Hansmann M. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 1993; 3 (5) 310-317
• 35 Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identified prior to 14 weeks’ gestation. Ultrasound Obstet Gynecol 2002; 20 (1) 22-29
• 36 McAuliffe FM, Trines J, Nield LE, Chitayat D, Jaeggi E, Hornberger LK. Early fetal echocardiography—a reliable prenatal diagnosis tool. Am J Obstet Gynecol 2005; 193 (3 Pt 2) 1253-1259
• 37 Weiner Z, Lorber A, Shalev E. Diagnosis of congenital cardiac defects between 11 and 14 weeks’ gestation in high-risk patients. J Ultrasound Med 2002; 21 (1) 23-29
• 38 Rasiah SV, Publicover M, Ewer AK, Khan KS, Kilby MD, Zamora J. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006; 28 (1) 110-116